![Bertram Köhler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bertram Köhler
Directeur Général chez
DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG
Profil
Bertram Köhler is Chief Executive Officer at Deutsche Effecten & Wechsel Beteiligungs AG since 2012, Chief Executive Officer at DEWB AG (Venture Capital) since 2012, Director-Supervisory Board at TME Pharma AG since 2014, Director at LemnaTec GmbH, Managing Director at DEWB Effecten GmbH, and Chief Investment Officer at Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) since 2003.
Former roles include Vice Chairman-Supervisory Board at SMARTRAC TECHNOLOGY Dresden GmbH, Director at Integrated Genomics, Inc., Director at Inpixon GmbH (Berlin), Director at DirectPhotonics Industries GmbH, Member-Supervisory Board at 4Flow AG, Member-Supervisory Board at TME Pharma NV from 2016 to 2021, and Member-Supervisory Board at aifinyo AG.
Postes actifs de Bertram Köhler
| Sociétés | Poste | Début |
|---|---|---|
| DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Directeur Général | 01/01/2012 |
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt)
 Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) Investment ManagersFinance Specializes in private equity fund | Directeur en chef des Investissements | 04/09/2003 |
DEWB AG (Venture Capital)
 DEWB AG (Venture Capital) Investment ManagersFinance DEWB-VC is a hands-on manager which invests in young and established German, Austrian and Swiss medium-sized growth companies in the photonics and sensor systems, including generation (lasers, bulbs), manipulation (lenses, gratings), transfer (optical fibre), conversion (solar cells, LED), storage (CD, DVD, holograms), visualization (displays) and exploitation (water sterilization using UV rays.) The firm prefers to act as lead investor, seeking to increase investee company value by taking significant minority stakes and typically investing between EUR 1-EUR 7 million for three to seven years. They seek to invest in companies with registered offices in Germany, Austria or Switzerland which have experienced management, strategic vision, an established network in their relevant market, products and services with a unique selling point in a strong growth market, an established client base and innovative, patentable technology. Through their network, DEWB-VC provides scientific and industrial support to their investee companies, aiming to create value up to exit, typically in the form of an IPO, trade sale or buy-back. | Directeur Général | 01/01/2000 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Directeur/Membre du Conseil | 16/11/2009 |
LemnaTec GmbH
 LemnaTec GmbH Packaged SoftwareTechnology Services Develops digital phenotyping and seed testing technology solutions | Directeur/Membre du Conseil | - |
DEWB Effecten GmbH
 DEWB Effecten GmbH Financial ConglomeratesFinance Operates as an investment holding company | Directeur Général | - |
Anciens postes connus de Bertram Köhler
| Sociétés | Poste | Fin |
|---|---|---|
| TME PHARMA N.V. | Directeur/Membre du Conseil | 24/06/2021 |
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression | Directeur/Membre du Conseil | 10/06/2011 |
| AIFINYO AG | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Deutsche Effecten & Wechsel Beteiligungs AG
 Deutsche Effecten & Wechsel Beteiligungs AG Financial ConglomeratesFinance Operates as a private equity firm | Finance |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression | Commercial Services |
Nanotron Technologies GmbH
 Nanotron Technologies GmbH Telecommunications EquipmentElectronic Technology Manufactures wireless communications systems | Electronic Technology |
SMARTRAC TECHNOLOGY Dresden GmbH
 SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology Designs, manufactures, and tests electronic and electromechanical components | Electronic Technology |
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt)
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) Investment ManagersFinance Specializes in private equity fund | Finance |
4Flow AG
 4Flow AG Packaged SoftwareTechnology Services Offers consulting services and software in the field of logistics and supply chain management | Technology Services |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB-VC is a hands-on manager which invests in young and established German, Austrian and Swiss medium-sized growth companies in the photonics and sensor systems, including generation (lasers, bulbs), manipulation (lenses, gratings), transfer (optical fibre), conversion (solar cells, LED), storage (CD, DVD, holograms), visualization (displays) and exploitation (water sterilization using UV rays.) The firm prefers to act as lead investor, seeking to increase investee company value by taking significant minority stakes and typically investing between EUR 1-EUR 7 million for three to seven years. They seek to invest in companies with registered offices in Germany, Austria or Switzerland which have experienced management, strategic vision, an established network in their relevant market, products and services with a unique selling point in a strong growth market, an established client base and innovative, patentable technology. Through their network, DEWB-VC provides scientific and industrial support to their investee companies, aiming to create value up to exit, typically in the form of an IPO, trade sale or buy-back. | Finance |
LemnaTec GmbH
LemnaTec GmbH Packaged SoftwareTechnology Services Develops digital phenotyping and seed testing technology solutions | Technology Services |
DirectPhotonics Industries GmbH
 DirectPhotonics Industries GmbH SemiconductorsElectronic Technology Develops, manufactures and sells diode laser systems | Electronic Technology |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
aifinyo AG
 aifinyo AG Finance/Rental/LeasingFinance Provides commodity financing, factoring and debt collection services | Finance |
DEWB Effecten GmbH
DEWB Effecten GmbH Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Choisissez Zonebourse 
